MedPath

Preventive Effects of Ketorolac and Nephaazolin- Anthrazoline Drops on Reducing Patient's Ocular Complications

Phase 3
Conditions
Cataract.
Age-related cataract
Registration Number
IRCT20200217046523N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
54
Inclusion Criteria

All of the Patients undergoing Phacoamulsification Surgery under sedation

Exclusion Criteria

Patients with glaucoma, uncontrolled hypertension, kidney disease, allergies to sedatives or studied
Proven psycho-anxiety disorders
Inability to follow up patients up to 0.5 hours after recovery
History of allergy or allergic reaction to Sedatives or studies
Any sensitivity to ketorolac

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ocular Complaints. Timepoint: Every 15 minutes in the recovery unit and in the ward for half an hour until discharge from the hospital. Method of measurement: Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath